Annex Eligible actionsF1

The following actions may be financed in case of pandemics with large‐scale effect:

1. (a)

   temporary reinforcement of the medical workforce, exchange of medical professionals, hosting foreign patients or other type of mutual support;

2. (b)

   deployment of temporary healthcare facilities and temporary extension of existing healthcare facilities to relieve pressure on existing structures and increase overall healthcare capacity;

3. (c)

   activities to support the administration of large‐scale application of medical tests and prepare the necessary scientific testing strategies and protocols;

4. (d)

   setting up temporary quarantine facilities and other appropriate measures at the Union borders;

5. (e)

   development, production or purchase and distribution of medical products;

6. (f)

   increases and conversions of production capacities for medical products as referred to in point (e) to address supply shortages;

7. (g)

   maintenance of the stock of medical products as referred to in point (e) and their disposal;

8. (h)

   actions to support the necessary steps to obtain approval for the use of the medical products as referred to in point (e) if required;

9. (i)

   actions to develop appropriate methods to track the development of the pandemic and the results of measures implemented to address it;

10. (j)

    organisation of ad‐hoc clinical trials of potential therapies or diagnostics according to trial standards agreed at Union level;

11. (k)

    scientific validation of medical products, including potential new testing methods.

The above list is not exhaustive.